Takeda to Establish Four Sales and Marketing Subsidiaries
- Details
- Category: Takeda
![Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited](http://www.worldpharmanews.com/images/stories/logo/takeda.gif)
Novartis oral MS therapy FTY720 significantly reduces relapses and disability progression
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Merck Submits Application for Cladribine Tablets
- Details
- Category: Merck Group
![Merck KGaA Merck KGaA](http://www.worldpharmanews.com/images/stories/logo/merck_kgaa.gif)
The Lilly TB Drug Discovery Initiative Announces New Collaborator
- Details
- Category: Eli Lilly and Company
![Lilly Lilly](http://www.worldpharmanews.com/images/stories/logo/lilly.gif)
Abbott to Acquire Solvay Pharmaceuticals Business
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
Novartis bronchodilator QAB149 recommended for approval in European Union
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Results from Abbott's PROSPECT Study Provide New Insight
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
More Pharma News ...
- Herceptin provides impressive survival benefit for patients with high levels of HER2
- Results of ADAGIO study with Azilect® in Parkinson's disease published
- Nexavar® Demonstrates 74 Percent Improvement in Progression-Free Survival
- Analysis of BRAIN study shows that patients may have a stabilisation or improvement
- Denosumab Demonstrates Superiority Over Zometa(R)
- Pfizer and Wyeth to Divest Certain Animal Health Assets to Boehringer Ingelheim
- Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO-ESMO Congress 2009